304 related articles for article (PubMed ID: 24987060)
41. Acetylation and methylation profiles of H3K27 in porcine embryos cultured in vitro.
Marinho LSR; Rissi VB; Lindquist AG; Seneda MM; Bordignon V
Zygote; 2017 Oct; 25(5):575-582. PubMed ID: 28693635
[TBL] [Abstract][Full Text] [Related]
42. Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas.
Bender S; Tang Y; Lindroth AM; Hovestadt V; Jones DT; Kool M; Zapatka M; Northcott PA; Sturm D; Wang W; Radlwimmer B; Højfeldt JW; Truffaux N; Castel D; Schubert S; Ryzhova M; Seker-Cin H; Gronych J; Johann PD; Stark S; Meyer J; Milde T; Schuhmann M; Ebinger M; Monoranu CM; Ponnuswami A; Chen S; Jones C; Witt O; Collins VP; von Deimling A; Jabado N; Puget S; Grill J; Helin K; Korshunov A; Lichter P; Monje M; Plass C; Cho YJ; Pfister SM
Cancer Cell; 2013 Nov; 24(5):660-72. PubMed ID: 24183680
[TBL] [Abstract][Full Text] [Related]
43. Quantitative proteomics reveals that the specific methyltransferases Txr1p and Ezl2p differentially affect the mono-, di- and trimethylation states of histone H3 lysine 27 (H3K27).
Zhang C; Molascon AJ; Gao S; Liu Y; Andrews PC
Mol Cell Proteomics; 2013 Jun; 12(6):1678-88. PubMed ID: 23150054
[TBL] [Abstract][Full Text] [Related]
44. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.
Dubuc AM; Remke M; Korshunov A; Northcott PA; Zhan SH; Mendez-Lago M; Kool M; Jones DT; Unterberger A; Morrissy AS; Shih D; Peacock J; Ramaswamy V; Rolider A; Wang X; Witt H; Hielscher T; Hawkins C; Vibhakar R; Croul S; Rutka JT; Weiss WA; Jones SJ; Eberhart CG; Marra MA; Pfister SM; Taylor MD
Acta Neuropathol; 2013 Mar; 125(3):373-84. PubMed ID: 23184418
[TBL] [Abstract][Full Text] [Related]
45. The expanding landscape of 'oncohistone' mutations in human cancers.
Nacev BA; Feng L; Bagert JD; Lemiesz AE; Gao J; Soshnev AA; Kundra R; Schultz N; Muir TW; Allis CD
Nature; 2019 Mar; 567(7749):473-478. PubMed ID: 30894748
[TBL] [Abstract][Full Text] [Related]
46. Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer.
Tran TQ; Lowman XH; Kong M
Clin Cancer Res; 2017 Aug; 23(15):4004-4009. PubMed ID: 28404599
[TBL] [Abstract][Full Text] [Related]
47. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.
Berg T; Thoene S; Yap D; Wee T; Schoeler N; Rosten P; Lim E; Bilenky M; Mungall AJ; Oellerich T; Lee S; Lai CK; Umlandt P; Salmi A; Chang H; Yue L; Lai D; Cheng SW; Morin RD; Hirst M; Serve H; Marra MA; Morin GB; Gascoyne RD; Aparicio SA; Humphries RK
Blood; 2014 Jun; 123(25):3914-24. PubMed ID: 24802772
[TBL] [Abstract][Full Text] [Related]
48. A histone H3 lysine 27 demethylase regulates animal posterior development.
Lan F; Bayliss PE; Rinn JL; Whetstine JR; Wang JK; Chen S; Iwase S; Alpatov R; Issaeva I; Canaani E; Roberts TM; Chang HY; Shi Y
Nature; 2007 Oct; 449(7163):689-94. PubMed ID: 17851529
[TBL] [Abstract][Full Text] [Related]
49. Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.
Castel D; Philippe C; Kergrohen T; Sill M; Merlevede J; Barret E; Puget S; Sainte-Rose C; Kramm CM; Jones C; Varlet P; Pfister SM; Grill J; Jones DTW; Debily MA
Acta Neuropathol Commun; 2018 Nov; 6(1):117. PubMed ID: 30396367
[TBL] [Abstract][Full Text] [Related]
50. Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones.
Sarthy JF; Meers MP; Janssens DH; Henikoff JG; Feldman H; Paddison PJ; Lockwood CM; Vitanza NA; Olson JM; Ahmad K; Henikoff S
Elife; 2020 Sep; 9():. PubMed ID: 32902381
[TBL] [Abstract][Full Text] [Related]
51. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.
Sneeringer CJ; Scott MP; Kuntz KW; Knutson SK; Pollock RM; Richon VM; Copeland RA
Proc Natl Acad Sci U S A; 2010 Dec; 107(49):20980-5. PubMed ID: 21078963
[TBL] [Abstract][Full Text] [Related]
52. Context-specific regulation of cancer epigenomes by histone and transcription factor methylation.
Sarris M; Nikolaou K; Talianidis I
Oncogene; 2014 Mar; 33(10):1207-17. PubMed ID: 23503463
[TBL] [Abstract][Full Text] [Related]
53. UTX-1 regulates Tat-induced HIV-1 transactivation via changing the methylated status of histone H3.
Zhang HS; Du GY; Liu Y; Zhang ZG; Zhou Z; Li H; Dai KQ; Yu XY; Gou XM
Int J Biochem Cell Biol; 2016 Nov; 80():51-56. PubMed ID: 27671333
[TBL] [Abstract][Full Text] [Related]
54. Histone H3 lysine 4 methyltransferase KMT2D.
Froimchuk E; Jang Y; Ge K
Gene; 2017 Sep; 627():337-342. PubMed ID: 28669924
[TBL] [Abstract][Full Text] [Related]
55. Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity.
Lavarone E; Barbieri CM; Pasini D
Nat Commun; 2019 Apr; 10(1):1679. PubMed ID: 30976011
[TBL] [Abstract][Full Text] [Related]
56. Selective inhibition of EZH2 by ZLD10A blocks H3K27 methylation and kills mutant lymphoma cells proliferation.
Song X; Zhang L; Gao T; Ye T; Zhu Y; Lei Q; Feng Q; He B; Deng H; Yu L
Biomed Pharmacother; 2016 Jul; 81():288-294. PubMed ID: 27261606
[TBL] [Abstract][Full Text] [Related]
57. Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis.
Thompson LL; Guppy BJ; Sawchuk L; Davie JR; McManus KJ
Cancer Metastasis Rev; 2013 Dec; 32(3-4):363-76. PubMed ID: 23609752
[TBL] [Abstract][Full Text] [Related]
58. Deregulation of H3K27 methylation in cancer.
Martinez-Garcia E; Licht JD
Nat Genet; 2010 Feb; 42(2):100-1. PubMed ID: 20104248
[TBL] [Abstract][Full Text] [Related]
59. Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma.
Lee CH; Yu JR; Granat J; Saldaña-Meyer R; Andrade J; LeRoy G; Jin Y; Lund P; Stafford JM; Garcia BA; Ueberheide B; Reinberg D
Genes Dev; 2019 Oct; 33(19-20):1428-1440. PubMed ID: 31488577
[TBL] [Abstract][Full Text] [Related]
60. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.
Bunt J; Hasselt NA; Zwijnenburg DA; Koster J; Versteeg R; Kool M
Acta Neuropathol; 2013 Mar; 125(3):385-94. PubMed ID: 23179372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
